Condition
Hypothalamic Obesity clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hypothalamic Obesity clinical trials that are recruiting, at sites in 2 countries (most in United States (2), United Kingdom (1)). By phase: Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using Tirzepatide to treat obesity in young adults with Prader-Willi Syndrome and hypothalamic obesity
This study is testing if a weight loss medication called Tirzepatide can help young adults with Prader-Willi Syndrome and hypothalamic obesity lose weight and improve their health.
-
Setmelanotide for congenital hypothalamic obesity
This will test whether daily setmelanotide injections help reduce weight, curb hunger, and improve quality of life in people aged 4 and older with congenital hypothalamic obesity.
Related topics
Quick answers
How many Hypothalamic Obesity clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.